Abstract
IL-10 is a potent immunosuppressant which inhibits allo-antigen-specific T cell responses. In addition, IL-10 is a strong endogenous anti-inflammatory cytokine. To investigate the role of IL-10 in the induction of acute GVHD following allogeneic bone marrow transplantation (BMT) we performed a prospective study on spontaneous IL-10 production by peripheral blood mononuclear cells (PBMNC) in 84 patients admitted for allogeneic BMT. High spontaneous IL-10 production by PBMNC at the time of admission and prior to any preparative treatment correlated with a subsequent low incidence of GVHD and transplant-related mortality (8%), as compared to patients with low or intermediate IL-10 production (50%, P < 0.01). Our data demonstrate the prognostic significance of increased IL-10 production in BMT patients and suggest a major role of IL-10 in maintaining immunobalance in the setting of allogeneic BMT. Bone Marrow Transplantation (2000) 25, 237–241.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Xun CQ, Thompson JS, Jennings CD et al. Effect of total body irradiation, busulfan-cyclophosphamide, or cyclophosphamide conditioning on inflammatory cytokine release and development of acute and chronic graft-versus-host disease in H-2-incompatible transplanted SCID mice Blood 1994 83: 2360–2367
Cooke KR, Kobzik L, Martin TR et al. An experimental model of idiopathic syndrome after bone marrow transplantation: I. The role of minor H antigens and endotoxin Blood 1996 88: 3230–3239
Holler E, Kolb HJ, Mittermueller J et al. Modulation of acute graft-versus-host disease after allogeneic bone marrow transplantation by tumor necrosis factor alpha (TNFa) release in the course of pretransplant conditioning: role of conditioning regimens and prophylactic application of a monoclonal antibody neutralizing human TNFa (MAK195F) Blood 1995 86: 890–899
Antin JH, Ferrara JLM . Cytokine dysregulation and acute graft-versus-host disease Blood 1992 80: 2964–2968
Antin JH, Weinstein HJ, Guinan EC et al. Recombinant human interleukin-1 receptor antagonist in the treatment of steroid resistant graft-versus-host disease Blood 1994 84: 1342–1348
Herve P, Flesch M, Tiberghien P et al. Phase I–II trial of a monoclonal anti-tumor necrosis factor alpha antibody for the treatment of refractory severe acute graft-versus-host disease Blood 1992 79: 3362–3368
de Waal Malefyt R, Yssel H, Roncarolo MG et al. Interleukin 10 Current Opin Immunol 1992 4: 314–320
Willems F, Marchant A, Delville JP . Interleukin 10 inhibits B7 and intercellular adhesion molecule-1 expression on human monocytes Eur J Immunol 1994 24: 1007–1009
Groux H, Bigler M, de Vries JE, Roncarolo MG . Interleukin-10 induces a long term antigen specific anergic state in human CD4+ T cells J Exp Med 1996 184: 19–29
Bacchetta R, Bigler M, Touraine JL et al. High levels of interleukin 10 production in vivo are associated with tolerance in SCID patients transplanted with HLA-mismatched hematopoietic stem cells J Exp Med 1994 179: 493–502
Blazar BR, Taylor PA, Smith S, Vallera DA . Interleukin-10 administration decreases survival in murine recipients of major histocompatibility complex disparate donor bone marrow grafts Blood 1995 85: 842
Krenger W, Snyder K, Smith S, Ferrara JLM . Effects of exogenous interleukin-10 in a murine model of graft-versus-host disease to minor histocompatibility antigens Transplantation 1994 58: 1251–1257
Hempel L, Korholz D, Nussbaum P et al. High interleukin-10 serum levels are associated with fatal outcome in patients after bone marrow transplantation Bone Marrow Transplant 1997 20: 365–368
Remberger M, Ringden O . Serum levels of cytokines after bone marrow transplantation: increased IL-8 levels during severe veno-occlusive disease of the liver Eur J Haematol 1997 59: 254–262
Holler E, Kolb HJ, Möller A et al. Increased serum levels of tumor necrosis factor alpha precede major complications of bone marrow transplantation Blood 1990 75: 1011–1016
Holler E, Kolb HJ, Hintermeier-Knabe R et al. Role of tumor necrosis factor alpha in acute graft-versus-host disease and complications following allogeneic bone marrow transplantation Transplant Proc 1993 25: 1234–1236
Eissner G, Lindner H, Behrends U et al. Influence of bacterial endotoxin on radiation-induced activation of human endothelial cells in vitro and in vivo: protective role of IL-10 Transplantation 1996 62: 819–827
Lindner H, Holler E, Gerbitz A et al. Influence of bacterial endotoxin on radiation-induced activation of human endothelial cells in vitro and in vivo: 2. IL-10 protects against transendothelial migration Transplantation 1997 64: 1370–1373
Steinbrink K, Wölfl M, Jonuleit H et al. Induction of tolerance by IL-10 treated dendritic cells J Immunol 1997 159: 4772–4780
Cortes JE, Talpaz M, Cabanillas F et al. Serum levels of interleukin 10 in patients with diffuse large cell lymphoma: lack of correlation with prognosis Blood 1995 85: 2516–2520
Pawelec G, Rehbein A, Schlotz E, da Silva P . Cellular immune responses to autologous chronic myelogenous leukemia cells in vitro Cancer Immunol Immunother 1996 42: 193–199
Wanidworanum C, Strober W . Predominant role of tumor necrosis factor alpha in human monocyte IL-10 synthesis J Immunol 1993 151: 6853–6861
Holler E, Hintermeier-Knabe R, Kolb HJ et al . Low incidence of transplant related complications in patients with chronic release of TNF alpha before admission in bone marrow transplantation – a clinical correlate of cytokine desensitization? Pathobiol 1991 59: 171–175
Barsig J, Küsters S, Vogt K et al. Lipopolysaccharide-induced interleukin-10 in mice: role of endogenous tumor necrosisfactor-α Eur J Immunol 1995 25: 2888–2893
Middleton PG, Taylor PR, Jackson G et al. Cytokine gene polymorphisms associating with severe acute graft-versus-host disease in HLA-identical sibling transplants Blood 1998 92: 3943–3948
Mayer F, Messer G, Knak W et al. High response of TNF-α secretion in vivo in patients undergoing BMT may be associated with the -308 bp TNF-α gene enhancer polymorphism Bone Marrow Transplant 1996 17: S101
Groux H, O’ Garra A, Bigler M et al. A CD4+ T-cell subset inhibits antigen specific T-cell responses and prevents colitis Nature 1997 389: 737–742
Howard M, Muchamuel T, Andrade S, Menon S . Interleukin 10 protects mice from lethal endotoxemia J Exp Med 1993 177: 1205–1208
Greenberger MJ, Strieter RM, Kunkel SL et al. Neutralization of IL-10 increases survival in a murine model of Klebsiella pneumonia J Immunol 1995 155: 722–729
Acknowledgements
We wish to acknowledge the help of the nurses of the BMT unit in collection of blood samples. We appreciate the skillful technical assistence of M Albiez, E Rustige, M Schreglmann and M Bigler in performing PBMNC cultures and ELISAs. This work was supported by grants No. Ho1142/1-3/4 and Ei68/2-1 from the Deutsche Forschungsgemeinschaft (DFG).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Holler, E., Roncarolo, M., Hintermeier-Knabe, R. et al. Prognostic significance of increased IL-10 production in patients prior to allogeneic bone marrow transplantation. Bone Marrow Transplant 25, 237–241 (2000). https://doi.org/10.1038/sj.bmt.1702126
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bmt.1702126
Keywords
This article is cited by
-
IL-10 promoter polymorphism associated with decreased risk of aGvHD after stem cell transplantation: a meta-analysis
International Journal of Hematology (2013)
-
Cytokine gene polymorphisms and graft-versus-host disease in children after matched sibling hematopoietic stem cell transplantation: a single-center experience
Cellular & Molecular Immunology (2011)
-
Interleukin-10 repletion suppresses pro-inflammatory cytokines and decreases liver pathology without altering viral replication in murine cytomegalovirus (MCMV)-infected IL-10 knockout mice
Inflammation Research (2011)
-
Association of interleukin-10 gene variation with breast cancer prognosis
Breast Cancer Research and Treatment (2010)
-
Production of IL-10 by alloreactive sibling donor cells and its influence on the development of acute GVHD
Bone Marrow Transplantation (2006)